SMMT · US market

Summit Therapeutics, Inc.

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$13.31bnFinancials dated 30 June 2026Price dated 1 October 2026

Core valuation

Trailing P/E-15.55×

Latest-quarter run-rate P/E-15.43×

Trailing P/SUnavailable

Latest-quarter run-rate P/SUnavailable

Calculation inputs

Trailing earnings: -US$856.09m
Latest-quarter run-rate earnings: -US$862.80m
Latest fiscal-year earnings: -US$1.08bn
Trailing revenue: Unavailable
Latest-quarter run-rate revenue: Unavailable
Latest fiscal-year revenue: Unavailable

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

XBI · State Street SPDR S&P Biotech ETF0.89% weight · Holdings dated 21 August 2026
QQQJ · Invesco NASDAQ Next Gen 100 ETF0.63% weight · Holdings dated 31 May 2026
GSEW · Goldman Sachs Equal Weight U.S. Large Cap Equity ETF0.19% weight · Holdings dated 31 May 2026
TNXT · T. Rowe Price Innovation Leaders ETF0.19% weight · Holdings dated 30 June 2026
FLXSX · Fidelity Flex Small Cap Index Fund0.12% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
IBB · iShares Biotechnology ETF0.12% weight · Holdings dated 19 August 2026
EQAL · Invesco Russell 1000 Equal Weight ETF0.09% weight · Holdings dated 31 May 2026
SHSSX · BlackRock Health Sciences Opportunities Portfolio Institutional Shares0.08% weight · Holdings dated 29 May 2026
BMED · iShares Health Innovation Active ETF0.07% weight · Holdings dated 21 August 2026
FXSCX · Fidelity Flex Small Cap Focused Index Fund0.07% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 30 June 2026. Informational research, not investment advice.